top of page

FDA Warns of Serious Potential for Tianeptine Misuse

Ann Tucker

The FDA recently released an alert warning consumers about the possible health effects of tianeptine and to avoid all products containing tianeptine. Although other countries have approved tianeptine to treat depression and anxiety, some have restricted how tianeptine is prescribed or dispensed, or revised the drug label to warn of possible addiction. Tianeptine has a potential for misuse, and people with a history of opioid use disorder or dependence may be at particular risk when using tianeptine.

Recent Posts

See All

Comentarios


Subscribe to the CLASPP Newsletter

Our members and supporters stay informed. From state and federal policy news to training and webinar events, funding opportunities and more, CLASPP brings it to you first.

Thanks for submitting!

© 2022 by CLASPP

bottom of page